Navigation Links
Kaiser Permanente Joins With Top Health Care Groups to Create Healthier Hospital Environments
Date:10/18/2007

Hospitals for a Healthy Environment.

The initiative kicked off Oct. 17 with a meeting in Oakland, Calif., where the group announced plans to work together on high-priority objectives, including:

-- A purchasing task force to prioritize safer and environmentally

sustainable products and supplies, and a sector-wide sustainable

purchasing strategy to drive markets for cleaner energy, safer

products, and innovative green technologies.

-- The development of a new eco-footprint model for health care to engage

the sector in policies to support an agenda that includes avoiding

toxic, hazardous materials -- areas not previously included in

eco-footprint analyses.

-- The establishment of a research collaborative to provide the evidence

and justification to remove obstacles to innovations in the health care

environment.

-- Creation of an open-source community to share best practices in the

construction and operation of energy efficient, non-toxic health care

environments.

The Global Health and Safety Initiative Co-Founders: Allina Hospitals and Clinics, Ascension Health, Bon Secours, Catholic Healthcare West, Cleveland Clinic Foundation, Geisinger Health System, Health Alliance of Greater Cincinnati, Henry Ford Health Systems, Hospital Sisters Health Systems, Kaiser Permanente, Presbyterian Healthcare Services - Albuquerque, St. Joseph of Orange, University of California - San Francisco Medical Center, University of Chicago Medical Center, University of Michigan Medical Center, The Center for Health Design, Health Care Without Harm, Hospitals for a Healthy Environment.

Supporting Non-profit Organizations: American Nurses Association, American Society for Healthcare Engineering, Green Guide for Healthcare, Institute for Healthcare Improvement, Joint Commission, U.S. Green Building Council.

Supporting Government Agencies: U.S. Centers for
'/>"/>

SOURCE Kaiser Permanente
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Ranbaxy joins hand with Cipla to co-market ciprofloxacin
2. Rat joins list of cloned animals
3. Richard Gere Joins Indian Stars For Fight Against AIDS
4. Enbrel Joins with Methotrexate to Cure Rheumatoid Arthritis
5. Anoushka Joins Hands With WFP to Feed the Poor
6. India Joins Hands With Global Body for Vaccine Research
7. Another Statewide Organization Joins the Fight Against Assisted Suicide
8. Two-year-old Joins Mensa, Becomes Its Youngest Ever Genius
9. Poor health care in Russia maybe causing Decline in its Population
10. Startling Expose – Physicians Often Have No Regular Source Of Health Car
11. Debate Rages over firing of HIV infected health care workers
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/15/2008)...iven in conjunction with cancer vaccines may boost...g the effectiveness of this promising type of canc... the Duke Comprehensive Cancer Center. , Chemoth...press immune function and we speculated that this ...junction with vaccines, which work by boosting imm...
(Date:5/15/2008)...ected to enhance service levels and expand ... CITY, South Korea, May 15 /PRNewswire/ -- Today, ...west technical ceramics manufacturing,facility in ...igh-purity,and other specialty ceramics, primarily...l display industries, fueled the additional facili...
(Date:5/15/2008)...wswire/ -- LifeCare Holdings, Inc. (the,"Company")...st quarter,ended March 31, 2008., Net Revenues, ...million, or 7.8%, for,the three months ended March... the comparable period in 2007. Patient days in th...e same period in 2007., The increase in our net p...
(Date:5/15/2008)...ire-FirstCall/ - QLT Inc. (NASDAQ: QLTI; TSX:,QLT)...chase agreement to,sell the land and building comp...undeveloped parcel of land in Vancouver, British C...ction, QLT will enter into a,five-year lease of sp..."We are very pleased that our strategic efforts to...
Breaking Medicine News(10 mins):Health News:Chemotherapy might help cancer vaccines work 2Health News:CoorsTek Holds Grand Opening for Newest Facility in South Korea 2Health News:CoorsTek Holds Grand Opening for Newest Facility in South Korea 3Health News:LifeCare Holdings, Inc. Announces First Quarter Results 2Health News:LifeCare Holdings, Inc. Announces First Quarter Results 3Health News:LifeCare Holdings, Inc. Announces First Quarter Results 4Health News:LifeCare Holdings, Inc. Announces First Quarter Results 5Health News:LifeCare Holdings, Inc. Announces First Quarter Results 6Health News:LifeCare Holdings, Inc. Announces First Quarter Results 7Health News:LifeCare Holdings, Inc. Announces First Quarter Results 8Health News:LifeCare Holdings, Inc. Announces First Quarter Results 9Health News:QLT Inc. announces agreement for sale of real estate 2Health News:QLT Inc. announces agreement for sale of real estate 3
...ned Wednesday of sophisticated Asian-based rackets...ousands of people every year//.Dallas Mildenhall s...the proper ingredients to treat illnesses such as ...vents and even remains of insects. Mildenhall, who...
... common crime with studies showing that around one...east once//. These shocking figures were compiled...'s Medical Research Council. Interviews of 1,370 ... revealed about 8 per cent who admitted to sexuall...
...-changing operations unless they agree to kick the...hospitals say that they will not treat patients fo... to give up on smoking. Those who do not stop the ... Smokers are at a big risk of complications and th...
...ealth should not be discouraged from drinking by d... study of nearly 9,000 men in the US showed that//...ack. The studies showed that men who drank around...l every day on average demonstrated nearly a third...
Other Medicine News:Health News:New Zealand Scientist Warns On Fake Drugs 2Health News:Smokers Warned to Give up else Face Denial of Operations 2Health News:Smokers Warned to Give up else Face Denial of Operations 3
(Date:5/14/2008)...pps Florida and Scripps Research in La ... Calif., and LA JOLLA, Calif., May 14 /PRNewswire-...aq: PARD ), a,biopharmaceutical company focused o...non-profit biomedical research organization, today...ensing classes of protein kinase,inhibitors for th...
(Date:5/14/2008)...s advocate to lead expansion of Cytel,s ... CAMBRIDGE, Mass., May 14 /- Cytel I...ervices and specialized statistical software,toda...ice President,Adaptive Trials., Judith Quinlan b...to,the Cytel team. Prior to joining Cytel Judith s...
(Date:5/14/2008)...ire-FirstCall/ -- The Quigley,Corporation (Nasdaq:...onducted by its wholly owned subsidiary, Quigley P...luate the anti-viral activity of its compound,QR44... had been infected,with Infectious Bronchitis Viru...448(a) is efficacious against an IBV challenge in ...
(Date:5/13/2008)...-USNewswire/ -- In women at increased,risk for bre...ion to,routine mammography revealed 28 percent mor...itional ultrasound exam substantially increased th... biopsies, according to an,American College of Rad...the May 14, 2008 issue of the Journal of American ...
Breaking Medicine Technology:Poniard Pharmaceuticals Licenses Kinase Inhibitors From The Scripps Research Institute 2Poniard Pharmaceuticals Licenses Kinase Inhibitors From The Scripps Research Institute 3Poniard Pharmaceuticals Licenses Kinase Inhibitors From The Scripps Research Institute 4Judith Quinlan Joins Cytel as Vice President, Adaptive Trials 2Quigley Announces Successful Poultry Study of Chickens With Infectious Bronchitis; Plans to Approach the Poultry Industry for Potential Commercialization 2Quigley Announces Successful Poultry Study of Chickens With Infectious Bronchitis; Plans to Approach the Poultry Industry for Potential Commercialization 3Quigley Announces Successful Poultry Study of Chickens With Infectious Bronchitis; Plans to Approach the Poultry Industry for Potential Commercialization 4Quigley Announces Successful Poultry Study of Chickens With Infectious Bronchitis; Plans to Approach the Poultry Industry for Potential Commercialization 5Adding Breast Ultrasound Screening to Mammography Reveals Cancers not Seen on Mammography Alone in Women at Increased Risk for Breast Cancer 2Adding Breast Ultrasound Screening to Mammography Reveals Cancers not Seen on Mammography Alone in Women at Increased Risk for Breast Cancer 3CTG Announces 2008 First Quarter Conference Call and Webcast Information 17120 1CTG Announces 2008 First Quarter Conference Call and Webcast Information 17120 2Ezra Susser MD DrPH receives Distinguished Investigator Award from NARSAD 17118 1Ezra Susser MD DrPH receives Distinguished Investigator Award from NARSAD 17118 2APIC Conference to Address New CMS Regulations 17115 1APIC Conference to Address New CMS Regulations 17115 2MSA Schedules First Quarter Earnings Webcast 17111 1MSA Schedules First Quarter Earnings Webcast 17111 2
...mmunization with a Bavituximab Equivalent and Irra... 57% From 0% in Controls in a,Preclinical Model of...pril 18, 2007,/PRNewswire-FirstCall/ -- Peregrine ...ceutical company developing targeted,monoclonal an... C,virus (HCV) infection, today announced preclini...
... YORK--(BUSINESS WIRE)--Apr 18, 2007 - INNOVIVE Ph...om preclinical evaluation of the,company,s drug ca...ent of a variety of tumor types. Researchers found...s to circulating,albumin and becomes activated onc...ted in animal models than doxorubicin alone, a,com...
Other Medicine Technology:Data Presented at AACR Meeting Show Peregrine's Bavituximab,Equivalent Can Generate Curative Immune Responses as Part of a,Vaccine-Like Regimen in Preclinical Models of Aggressive Brain,Cancer 2Data Presented at AACR Meeting Show Peregrine's Bavituximab,Equivalent Can Generate Curative Immune Responses as Part of a,Vaccine-Like Regimen in Preclinical Models of Aggressive Brain,Cancer 3Data Presented at AACR Meeting Show Peregrine's Bavituximab,Equivalent Can Generate Curative Immune Responses as Part of a,Vaccine-Like Regimen in Preclinical Models of Aggressive Brain,Cancer 4Data Presented at AACR Meeting Show Peregrine's Bavituximab,Equivalent Can Generate Curative Immune Responses as Part of a,Vaccine-Like Regimen in Preclinical Models of Aggressive Brain,Cancer 5Data Presented at AACR Meeting Show Peregrine's Bavituximab,Equivalent Can Generate Curative Immune Responses as Part of a,Vaccine-Like Regimen in Preclinical Models of Aggressive Brain,Cancer 6Innovive Pharmaceuticals Announces Preclinical Data from INNO-206,Oncology Program 2Innovive Pharmaceuticals Announces Preclinical Data from INNO-206,Oncology Program 3
Our Wright stain is a dual-use stain for peripheral blood and bone marrow smears. It produces results similar to those of the Giemsa stain with a slightly greater contrast.
Albumin reagent is used for the quantitative determination of albumin concentration in human serum.
AST (SGOT) reagent is used for the quantitative determination of aspartate aminotransferase (AST) in human serum.
Intended for the quantitative determination of aspartate aminotransferase activity in serum or plasma. Reaction: Kinetic. Wavelength: 340 nm. Linearity: 440 U/L at 30C. Single vial, dry powder reagen
Medicine Products: